Zhao, X., Qu, K., Curci, B., Yang, H.
, Bolund, L., Lin, L. & Luo, Y. (2023).
Comparison of In-Frame Deletion, Homology-Directed Repair, and Prime Editing-Based Correction of Duchenne Muscular Dystrophy Mutations.
Biomolecules,
13(5), Article 870.
https://doi.org/10.3390/biom13050870
Zhang, Z., Shahinfar, S., Keane, W. F., Ramjit, D., Dickson, T. Z., Gleim, G. W.
, Mogensen, C. E. S., de Zeeuw, D., Brenner, B. M. & Snapinn, S. M. (2005).
Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
Journal of the American Society of Nephrology,
16, 1775-1780.
Zhang, X., Gu, H. F.
, Frystyk, J., Efendic, S., Brismar, K. & Thorell, A. (2019).
Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects.
Growth Hormone & I G F Research,
45, 31-36.
https://doi.org/10.1016/j.ghir.2019.03.002Zhang, C. D., Li, D., Kaur, R. J.
, Ebbehoj, A., Singh, S., Atkinson, E. J., Achenbach, S. J., Young, W. F., Arlt, W., Rocca, W. A. & Bancos, I. (2021).
Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting: A Population-Based Cohort Study.
The Journal of clinical endocrinology and metabolism,
106(11), 3320-3330.
https://doi.org/10.1210/clinem/dgab468Zhang, C., Li, C., Yang, L., Leng, L., Jovic, D., Wang, J., Fang, F., Li, G., Zhao, D., Li, X.
, Lin, L., Luo, Y., Bolund, L., Huang, J., Lin, G. & Xu, F. (2021).
The Dynamic Changes of Transcription Factors During the Development Processes of Human Biparental and Uniparental Embryos.
Frontiers in Cell and Developmental Biology,
9, Article 709498.
https://doi.org/10.3389/fcell.2021.709498Yuen, K.
, Frystyk, J., Umpleby, M., Fryklund, L. & Dunger, D. (2004).
Changes in free rather than total D: IGF-I insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults.
J. Clin. Endocrinol.,
89, 3956-3964.
Yuen, K., Wareham, N.
, Frystyk, J., Hennings, S., Mitchell, J., Fryklund, L. & Dunger, D. (2004).
Short-term low dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on β-cell function and post-load glucose tolerance.
European Journal of Endocrinology,
151, 39-45.